ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
8.92
+0.66 (7.99%)
At close: May 15, 2026, 4:00 PM EDT
8.98
+0.06 (0.67%)
After-hours: May 15, 2026, 7:36 PM EDT
ImmuCell Employees
ImmuCell had 73 employees as of December 31, 2025. The number of employees decreased by 2 or -2.67% compared to the previous year.
Employees
73
Change
-2
Growth
-2.67%
Revenue / Employee
$378,687
Profits / Employee
-$14,247
Market Cap
80.70M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Gossamer Bio | 162 |
| XBiotech | 85 |
| Fortress Biotech | 78 |
| Seres Therapeutics | 66 |
| PDS Biotechnology | 24 |
| Gain Therapeutics | 21 |
| Rallybio | 14 |
| Atara Biotherapeutics | 14 |
ICCC News
- 13 hours ago - ImmuCell Earnings Call Transcript: Q1 2026 - Transcripts
- 1 day ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026 - GlobeNewsWire
- 8 days ago - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026 - GlobeNewsWire
- 4 weeks ago - ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors - GlobeNewsWire
- 5 weeks ago - ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results - GlobeNewsWire
- 2 months ago - ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board - GlobeNewsWire
- 2 months ago - ImmuCell Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025 - GlobeNewsWire